Literature DB >> 9174104

Differential induction of growth arrest inducible genes by selenium compounds.

M Kaeck1, J Lu, R Strange, C Ip, H E Ganther, H J Thompson.   

Abstract

The effects of two types of selenium compounds on the expression levels of growth arrest and DNA damage-inducible (gadd) genes and on selected cell death genes were examined in mouse mammary MOD cells to test the hypothesis that the diversity of selenium-induced cellular responses to these compounds could be distinguished by unique gene expression patterns. Whereas the expression patterns of known cell death-related genes (bcl-2 and bax) were not informative with respect to the cellular response patterns upon exposure to selenium compounds, time-dependent and selenium species-specific induction patterns were observed for gadd34, gadd45 and gadd153 genes. It was also observed that the MOD cells expressed a truncated p53 transcript but no detectable immunoreactive P53 protein, indicating a null p53 phenotype. The fact that selenium compounds induced growth arrest and death of these cells and that these compounds induced specific patterns of expression of gadd genes indicates that these genes may mediate some selenium-induced cellular responses. The findings further imply that selenium compounds may be effective chemopreventive agents for human breast carcinogenesis, in which p53 mutations are frequent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174104     DOI: 10.1016/s0006-2952(97)00103-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  18 in total

1.  Heat induction of reporter gene expression via the gadd153 promoter and its possible application to hyperthermia treatment of cancer.

Authors:  I A Bouhon; A Ito; M Shinkai; H Honda; T Kobayashi
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

2.  The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2D.

Authors:  Michael Hagemann-Jensen; Franziska Uhlenbrock; Stephanie Kehlet; Lars Andresen; Charlotte Gabel-Jensen; Lars Ellgaard; Bente Gammelgaard; Søren Skov
Journal:  J Biol Chem       Date:  2014-09-25       Impact factor: 5.157

3.  Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response.

Authors:  T W Fawcett; J L Martindale; K Z Guyton; T Hai; N J Holbrook
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

Review 4.  Chemopreventive mechanisms of selenium.

Authors:  G F Combs
Journal:  Med Klin (Munich)       Date:  1999-10-15

Review 5.  Methylselenocysteine: a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs.

Authors:  Arup Bhattacharya
Journal:  Expert Opin Drug Deliv       Date:  2011-04-07       Impact factor: 6.648

6.  Differential effects of nanoselenium doping on healthy and cancerous osteoblasts in coculture on titanium.

Authors:  Phong A Tran; Love Sarin; Robert H Hurt; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2010-05-13

7.  Selenium Inhibits Metastasis of Murine Melanoma Cells through the Induction of Cell Cycle Arrest and Cell Death.

Authors:  Hyunkeun Song; Indo Hur; Hyun-Jin Park; Joohyung Nam; Ga Bin Park; Kyoung Hye Kong; Young Mi Hwang; Yeong Seok Kim; Dae Ho Cho; Wang Jae Lee; Dae Young Hur
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

8.  In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes.

Authors:  Weiqin Jiang; Cheng Jiang; Hongying Pei; Lei Wang; Jinhui Zhang; Hongbo Hu; Junxuan Lü
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

Review 9.  Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.

Authors:  Junxuan Lü; Jinhui Zhang; Cheng Jiang; Yibin Deng; Nur Özten; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2015-11-23       Impact factor: 2.900

10.  Rational design and optimization of selenophenes with basic side chains as novel potent selective estrogen receptor modulators (SERMs) for breast cancer therapy.

Authors:  Junjie Luo; Zhiye Hu; Yuan Xiao; Tongxin Yang; Chune Dong; Jian Huang; Hai-Bing Zhou
Journal:  Medchemcomm       Date:  2017-05-24       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.